Participated · Series G · Aug 2026

Form Energy develops iron-air long-duration batteries capable of delivering up to 100 hours of discharge. Its chemistry relies on iron oxidation and reduction, enabling lower-cost storage by avoiding higher-priced minerals like lithium, cobalt, and nickel. The company has secured large commercial customers including Google, Crusoe, Xcel Energy, and FuturEnergy Ireland and reports a commercial project backlog of about 80 gigawatt-hours. About 80% of the company’s materials supply is sourced from the U.S., with the remainder from Europe and Asia. Form is expanding manufacturing capacity in West Virginia following its recent financing. The company’s positioning and technology aim to address growing demand for long-duration storage as U.S. electricity demand rises and renewable generation expands.

Participated · Series G · Jun 2026

Helion Energy had been working toward a promised energy breakthrough but fell behind schedule and began running short on cash. The company's financial strain led to a high-profile fundraising effort in which Sam Altman, one of its largest investors, solicited OpenAI to lead a $500 million round at a $35 billion valuation. A significant portion of Altman's personal net worth is reported to be tied to Helion. Within the company, employees who reviewed the proposed financing raised doubts about the viability of the technology. Concern about potential legal exposure led some staff to avoid discussions about the deal in internal Slack channels. The article does not provide revenue, user, or other operating metrics, nor does it detail specific product plans beyond the referenced "energy breakthrough."

Led · Seed · Jan 2024

VenomAid Diagnostics has developed a portable in vitro diagnostic test that uses a small amount of patient blood to quickly identify the type of snake venom in the bloodstream. The test is designed to enable healthcare workers to rapidly and accurately diagnose snakebites so they can administer appropriate treatment, reducing time to treatment and the risk of death or permanent disability. Led by CEO Jonas Arnold Jürgensen, the company says its technology could transform snakebite management and bring affordable diagnostics to victims worldwide. The company intends to use the funds to expand operations and development efforts. VenomAid is gearing up for clinical pilots in Brazil and plans to initiate manufacturing of its rapid tests as it moves closer to market. The company is headquartered in Copenhagen, Denmark.

Participated · Series A · Sep 2022

New Leaf Dynamic Technologies builds cold-chain solutions centered on a biomass-powered refrigeration unit designed to replace conventional compressor technologies. The company raised ₹6.15 crore in equity in a pre-Series A round from US-based Good Ventures LLC and previously received seed funding and incubation support from Social Alpha and Indigram Labs Foundation. It plans to strengthen India’s cold-chain infrastructure, reduce post-harvest losses, and expand its product portfolio. New Leaf intends to scale distribution by making its biomass-powered units available to more channel partners serving India’s rural cold chain. The company provides access to finance for end-users—farmers and farmer-producer companies—through loan guarantees with banks and financial partners, and offers ground-level hand-holding to build storage infrastructure near farms or aggregation points. New Leaf currently supports 15,000 farmers and aims to impact the livelihoods and incomes of more than 200,000 small and marginal farmers in the next three years.

Led · Series A · Aug 2012

Vicarious applies unsupervised learning techniques and a Schema Networks approach to give robots an abstract, causal understanding of tasks that can transfer across environments. The company pursues generalized intelligence rather than a narrow commercial product, surfacing periodically with research milestones such as CAPTCHA-solving (2013) and an Atari Breakout-playing AI. Founded by Scott Phoenix and Dileep George in 2010, the team’s background includes Phoenix’s Frogmetrics and George’s Numenta. The recent funding is intended to expand its research team and build smarter robots. Vicarious does not have a formal, widely distributed product today, making long-term sustainability hard to judge. Financially, the company has raised an additional $50 million in this round, bringing total fundraising to $138 million according to PitchBook. Vicarious is an AI research company led by Dr. Dileep George and D. Scott Phoenix that develops software inspired by the computational principles of the brain. The company is based in San Francisco and was founded in 2010. It has raised nearly $70M in capital since founding. Recently Vicarious received a $12M investment from ABB Technology Ventures. ABB joined existing investors including Jeff Bezos, Peter Thiel and Marc Benioff. Vicarious intends to use the new funds to pursue its long‑term research goals. Vicarious developed technology that solved CAPTCHA queries last fall and is focused on rethinking core learning algorithms rather than relying on traditional convolutional neural networks. Co-founders D. Scott Phoenix and Dileep George draw on George’s Stanford doctoral work on hierarchical models of the brain to inform their approach. The company says its methods have produced leaps in performance and are intended to enable breakthroughs in robotics, clean energy, and medicine, ultimately toward what they describe as the world’s first intelligent machines. Vicarious just raised a new $40 million growth round from a broad set of investors, bringing total disclosed funding to $56.1 million. The round included a personal investment from Mark Zuckerberg, while other backers such as Dustin Moskovitz and Ashton Kutcher invested via their funds. The company has 10 employees and plans to grow its headcount significantly. Vicarious is developing software that thinks and learns like a human, driven by its Recursive Cortical Network. The system is designed to interpret the content of photos and videos in a human-like way. Potential applications the company cites include robotics, medical image analysis, and image and video search. Vicarious has been in research mode since launching in February 2011 and received early funding from Founders Fund, Dustin Moskovitz, Adam D’Angelo, Felicis Ventures, and Joe Lonsdale. It raised a $15 million Series A led by Good Ventures to expand R&D efforts. The founders say commercial products are still several years off and that they are proceeding cautiously, testing progress carefully.